BioMap - About the company
BioMap is a series A company based in Beijing (China), founded in 2020 by Robin LI. It operates as an AI-based precision medicine supporting tool for drug discovery. BioMap has raised an undisclosed amount in funding from Granite Asia. The company has 536 active competitors, including 163 funded and 99 that have exited. Its top competitors include companies like MedGenome, Geneoscopy and Intellia Therapeutics.
Company Details
AI-based precision medicine supporting tool for drug discovery. The company has developed software that uses AI technology for research and development. It has features for multi-omic data analysis, drug designing, and more.
- Website
- biomap.com
- Email ID
- *****@biomap.com
Key Metrics
Founded Year
2020
Location
Beijing, China
Stage
Series A
Latest Funding Round
Investors
Ranked
55th among 536 active competitors
Employee Count
89 as on Apr 30, 2026
Similar Companies
Sign up to download BioMap's company profile
BioMap's funding and investors
BioMap has raised funding over 1 round. Its latest funding round was a Series A round on Jul 30, 2021 for $*****. 5 investors participated in its latest round. BioMap has 6 institutional investors.
Here is the list of recent funding rounds of BioMap:
Date of Funding | Funding Amount | Round Name | Post-Money Valuation | Revenue Multiple | Lead Investors | Other Investors |
|---|---|---|---|---|---|---|
Jul 30, 2021 | 5988762 | Series A | 4269681 | 6463542 | 4387987 | 7695366 |
Access funding benchmarks and valuations. Sign up today!View details of BioMap's funding rounds and investors
BioMap's founders and board of directors
Founder? Claim ProfileThe founders of BioMap is Robin LI.
Here are the details of BioMap's key team members:
- Robin LI: Co-founder & CEO of BioMap. Contact Info: 1 email address
View details of BioMap's Founder profiles and Board Members
BioMap's employee count trend
BioMap has 89 employees as of Apr 26. Here is BioMap's employee count trend over the years:
Uncover BioMap's growth story! Sign up today!
Access Tracxn on any website
Install Tracxn ExtensionOur Google Chrome extension lets you view company details while browsing their websites
BioMap's Competitors and alternates
Top competitors of BioMap include MedGenome, Geneoscopy and Intellia Therapeutics. Here is the list of Top 10 competitors of BioMap, ranked by Tracxn score:
Get insights and benchmarks for competitors of 2M+ companies! Sign up today!
Rank | Company Details | Short Description | Total Funding | Investors | Tracxn Score |
|---|---|---|---|---|---|
1st | Provider of DNA sequencing, bioinformatics, and multiomics services | $264M | 71/100 | ||
2nd | Geneoscopy 2015, St. Louis (United States), Series C | Developer of non-invasive biomarker tests for colorectal cancer | $219M | 67/100 | |
3rd | Intellia Therapeutics 2014, Cambridge (United States), Public | Developer of therapeutics based on CRISPR/Cas9 technology for multiple diseases | $85M | 66/100 | |
4th | Caris Life Sciences 1996, Irving (United States), Public | Developer of panomic disease profiling technologies for cancer precision medicine | $1.23B | 66/100 | |
5th | Certara 2008, Princeton (United States), Public | Provider of a platform for in silico drug discovery and consulting services | - | 65/100 | |
6th |  Cartography Biosciences 2020, Foster City (United States), Series B | Provider of a platform to discover immunotherapeutics | $124M | 62/100 | |
7th |  UniQure 1998, Amsterdam (Netherlands), Public | Developer of gene-based therapies for patients with genetic or acquired diseases | $111M | 62/100 | |
8th |  Deep Genomics 2014, Toronto (Canada), Series C | AI-powered platform for RNA biology to accelerate genetic therapy discovery | $238M | 62/100 | |
9th | Exicure 2009, Skokie (United States), Public | developer of gene silencing & immunomodulatory drugs using spherical nucleic acid (SNA) technology | $72.3M | 61/100 | |
10th | GenSight Biologics 2011, Paris (France), Public | Developer of viral vector-based gene therapies for retinal neurodegenerative diseases | $76.6M | 61/100 | |
55th | AI-based precision medicine supporting tool for drug discovery | - | 51/100 |
Get insights and benchmarks for competitors of 2M+ companies! Sign up today!Looking for more details on BioMap's competitors? Click here to see the top ones
BioMap's Investments and acquisitions
BioMap has made 2 investments in C12.ai and AIxplorerBio. BioMap has not made any acquisitions as of now.Reports related to BioMap
Here is the latest report on BioMap's sector:
News related to BioMap
Media has covered BioMap for 1 event in last 1 year.
•
•
•
•
Sanofi pays $10M upfront in hope 'biological map of proteins' leads to drug discovery treasureFierce Biotech•Oct 10, 2023•BioMap, Sanofi
•
•
•
"Baitu Shengke" founded by Robin Li received hundreds of millions of US dollars in Series A financing, led by GGV Jiyuan CapitalPEdaily•Jul 29, 2021•BioMap, , Baidu, Legend Capital and 2 others
•
•
Get curated news about company updates, funding rounds, M&A deals and others. Sign up today!Are you a Founder ?
FAQs about BioMap
Explore our recently published companies
- Bernierobbins - Unfunded company
- Baronhats - United States based, Unfunded company
- Nivmeh - 2023 founded, Unfunded company
- eldoLED - United States based, 2005 founded, Unfunded company
- Right E-Waste Recycle - Unfunded company
- Connect Info Solutions - Mumbai based, 2012 founded, Unfunded company
